The lawsuit claims the companies violated state and federal controlled substance laws. They allegedly gave opioids better placement on the national registry of drugs in exchange for profitable rebates, failed to limit their excessive distribution into communities, dispensed opioids through mail order pharmacies without effectively controlling diversion, and colluded with Purdue Pharma in marketing opioids to increase their sales.
Express Scripts and OptumRX are two of the largest ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.
